Ontology highlight
ABSTRACT: Background
Novel wearable biosensors, ubiquitous smartphone ownership, and telemedicine are converging to enable new paradigms of clinical research. A new generation of continuous glucose monitoring (CGM) devices provides access to clinical-grade measurement of interstitial glucose levels. Adoption of these sensors has become widespread for the management of type 1 diabetes and is accelerating in type 2 diabetes. In parallel, individuals are adopting health-related smartphone-based apps to monitor and manage care.Objective
We conducted a proof-of-concept study to investigate the potential of collecting robust, annotated, real-time clinical study measures of glucose levels without clinic visits.Methods
Self-administered meal-tolerance tests were conducted to assess t
SUBMITTER: Roux de Bezieux H
PROVIDER: S-EPMC7974765 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature